AKT1 and metabolic dysfunction-associated steatotic liver disease: Their research showed that flavonoids such as quercetin and myricetin acted on key targets including AKT1, CFTR, and PIK3 regulatory subunit 1 (PIK3R1), inhibiting the cAMP signaling pathway in the liver and consequently reducing MASLD.